Mutant Presenilin proteins cause early-onset familial Alzheimer's disease in humans and Caenorhabditis elegans Presenilins may facilitate Notch receptor signaling. We have isolated a Drosophila Presenilin homologue and determined the spatial and temporal distribution of the encoded protein as well as its localization relative to the fly Notch protein. In contrast to previous mRNA in situ studies, we find that Presenilin is widely expressed throughout oogenesis, embryogenesis, and imaginal development, and generally accumulates at comparable levels in neuronal and nonneuronal tissues. Double immunolabeling with Notch antibodies revealed that Presenilin and Notch are coexpressed in many tissues throughout Drosophila development and display partially overlapping subcellular localizations, supporting a possible functional link between Presenilin and Notch.
Introduction
Alzheimer's disease is the most prevalent cause of dementia and memory loss in the elderly population. The disease is characterized by certain neuropathological features, including extracellular amyloid plaques, neurofibrillary tangles, and extensive loss of neurons in the brain (reviewed in Selkoe, 1996) . Progress in understanding the molecular basis of this disease has come from the recent identification of two related proteins, Presenilin 1 and 2 (PS1 and PS2), mutations in which are associated with an early-onset form of the disease (Levy-Lahad et al., 1995; Rogaev et al., 1995; Sherrington et al., 1995) . The two human Presenilin proteins are related proteins with a proposed structure of eight transmembrane domains and a single large hydrophilic loop Doan et al., 1996) . Although the biochemical functions of the Presenilins are not fully understood, they have been implicated in three seemingly disparate processes: b-amyloid deposition, Notch/Lin-12 signaling, and apoptosis. Alzheimer's disease-associated mutant Presenilins cause overproduction of the more neurotoxic long form of b-amyloid (Ab42) relative to the more benign short form (Ab40) (reviewed in Haass, 1997) . A connection between the Presenilins and Notch signaling has emerged from genetic screens in Caenorhabditis elegans, in which mutant forms of the Sel-12 Presenilin protein were first isolated as suppressors of a multivulva phenotype caused by overactive Notch/Lin-12 signaling activity (Levitan and Greenwald, 1995) . A second C. elegans Presenilin, termed Hop-1, has been discovered that may influence Lin-12 signaling in other nematode tissues (Li and Greenwald, 1997) . In addition, both Notch and its ligand Delta have been found to be underexpressed in the paraxial mesoderm of mice deficient for Presenilin 1 (Wong et al., 1997) . Finally, a possible link between the Presenilins and apoptosis has come from the findings that overexpression of Presenilin 2 induces apoptosis in PC12 and HeLa cells (Deng et al., 1996; Wolozin et al., 1996; Janicki and Monteiro, 1997) and that C-terminal fragments of Presenilin 2 have anti-apoptotic properties (Vito et al., 1997) .
We and others have identified a single Presenilin (Psn) homologue in Drosophila (Boulianne et al., 1997; Hong and Koo, 1997 ; this study), and we have produced antibodies that recognize the fly protein. Using these antibodies, we have performed a detailed analysis of the spatial and temporal expression pattern as well as the subcellular localization of Drosophila Presenilin. Previous studies relying upon mRNA in situ hybridization have concluded that Presenilin transcripts are enriched in neuronal tissues of the embryo (Hong and Koo, 1997) and accumulate in particular regions of imaginal tissues, such as the ocellar primordia of the eye disc and the femur and tibia primordia of the leg disc (Boulianne et al., 1997) . In contrast, we find that Presenilin is expressed widely throughout development, and is generally present at similar levels in neuronal and nonneuronal tissues. At the subcellular level, the protein accumulates primarily within the cytoplasm and at the cell membranes of various cell types. Given the proposed involvement of worm and mammalian Presenilins in Notch signaling (Levitan and Greenwald, 1995; Li and Greenwald, 1997; Wong et al., 1997) , we examined the degree of Notch and Presenilin colocalization in tissues known to require Notch signaling during morphogenesis. Based on the widespread expression of Presenilin and its high level of coexpression with Notch, we propose that Presenilin may act together with Notch to specify cell fates during the formation of different tissues throughout Drosophila development.
Results

Molecular characterization of Drosophila Presenilin
Using degenerate PCR, we isolated from Drosophila genomic DNA a 260 bp product encoding a partial protein with extensive similarity to human and nematode Presenilins (see Section 4). This product was used to screen a Drosophila embryonic cDNA library, resulting in the isolation of two alternatively spliced forms of Drosophila Presenilin (Psn) encoding 527 amino acid and 541 amino acid polypeptides, respectively, in agreement with other cDNA studies (Boulianne et al., 1997; Hong and Koo, 1997) . The Drosophila Psn amino acid sequence is ∼50% identical to human Presenilin 1 and 2, and shares ∼45% homology with the C. elegans Sel-12 protein, but only ∼30% identity with the C. elegans Hop-1 protein (Fig. 1A) . The similarity between the Drosophila and the human Presenilins extends over the entire length of the protein sequence except for the most N-terminal 91 amino acids and most of the hydrophilic loop region (Fig. 1B) . Drosophila Psn contains several wellconserved hydrophobic regions that represent putative transmembrane domains, corresponding to the proposed eight transmembrane domains of the human and nematode Presenilins.
We used in situ hybridization to determine the cytological localization of Drosophila Psn at position 77B/C on the third chromosome (data not shown), as reported by others (Boulianne et al., 1997) . PCR tests on P1 phage clones in this region identified DS02810, DS03290, DS04247, DS06850, and DS07540 as Psn-containing P1 clones, and excluded P1 phage clones DS00353, DS03009 and DS07711 (Berkeley Drosophila Genome Project, personal communication). Sequencing of genomic DNA subcloned from P1 clone DS02810 revealed a compact Psn gene structure that contains nine exons separated by eight small introns ranging in size from 53 to 248 bp (Fig. 1C) . Alternative 5′ splice donor usage for intron 7 generates the two cDNA variants differing with respect to a 14 amino acid insertion within the large loop domain. Previous reports have used the abbreviation Dps for this gene (Boulianne et al., 1997; Hong and Koo, 1997) . However, since this name is inconsistent with the accepted nomenclature guidelines of the Drosophila community (FlyBase, 1998) , and since the abbreviation PS is already used for the fly integrin genes, we propose the abbreviation Psn for the Drosophila Presenilin gene.
Production of Psn-specific antibodies
To generate Psn-specific polyclonal antibodies, a peptide from the hydrophilic loop region (amino acids 362-376), and a fusion protein containing loop region sequences (amino acids 358-483) were used as immunogens. Antibody specificity of affinity-purified antiserum L7 (loop peptide immunogen) was established by three methods. First, S2 cells transfected with Psn cDNAs under heat-shock control displayed heat-inducible immunoreactivity with this antiserum (data not shown). Identical results were obtained using a Myc-tagged Psn expression construct, followed by immunolabeling of transfected S2 cells with a Myc antibody (data not shown). Second, we ectopically expressed Psn in defined patterns in transgenic flies using the UAS-GAL4 system (Brand and Perrimon, 1993) , and detected high- ) ; however, all immunostainings described below were performed with affinity-purified antibody L7.
Expression and subcellular localization of Drosophila Psn during oogenesis and embryogenesis
We examined the expression of Psn during oogenesis and embryogenesis with an emphasis on its expression in neuronal tissues and its subcellular localization. During Drosophila oogenesis, each developing egg chamber consists of three cell types; the germline-derived oocyte, the associated 15 nurse cells and ∼1000 somatic follicle cells. Confocal immunohistological analysis of egg chambers showed that Psn is expressed mainly in nurse cells and follicle cells throughout oogenesis. Vesicular staining is seen throughout the anterior germarium region of each ovariole ( Fig. 2A) , and is limited to nurse cells and follicle cells of late-stage egg chambers ( Fig. 2B-E ). Psn protein is hardly detected within the oocyte in a stage 11 egg chamber (Fig. 2B ), which may simply reflect poor antibody penetration of this tissue (T. Jongens, personal communication). High levels of Psn are seen near membranes of the follicle cells and nurse cells whereas lower levels are detected in the cytoplasm of the nurse cells. In nurse cells, membrane staining appears to be confined to the apical membranes and pronounced Psn accumulation is seen around the nuclei. Given the reported nuclear membrane and kinetochore localization of mammalian Presenilins , we investigated this staining more carefully by double labeling with propidium iodide, which labels DNA, and wheat germ agglutinin, which labels the nuclear membrane ( Fig. 4D-I ). Our confocal imaging reveals that Psn does not colocalize with DNA in nurse cells, nor is it present within the nuclear membrane. The nuclear-associated Psn distribution appears to be cytoplasmic Psn accumulation adjacent to but not overlapping with the nuclear membrane.
As in oogenesis, Psn appears to be expressed in all or most cells during embryogenesis. Psn protein can be detected in early embryos and persists throughout all stages of embryonic development. During cellularization, Psn is present in all cells of the embryo, including the pole cells, and appears to be enriched near cell membranes (Fig. 2F,G) . During gastrulation, Psn expression is fairly ubiquitous but higher levels are apparent in ectoderm relative to mesoderm (Fig. 2J ). Increased expression in epidermal tissues persists in later stage embryos (Fig. 2K) , where Psn also appears to be present throughout the embryonic central nervous system (CNS) (Fig. 2I,K) . In contrast to a previous report of enhanced CNS-specific Psn mRNA expression (Hong and Koo, 1997) , we detect Psn protein in the embryonic nervous system at levels similar to those of neighboring, nonneuronal tissues. The subcellular localization of Psn in embryos is similar to that observed during oogenesis, as described above. In epidermal tissue such as epithelial cells of the hindgut, Psn may accumulate preferentially near apical membranes (Fig. 2H ).
Expression and subcellular localization in postembryonic tissues
The expression and the subcellular localization of Psn was determined in selected postembryonic Drosophila tissues. In larval imaginal discs, Psn expression was detected in all cells as far as we could determine (Fig. 3A,B ). Double labeling of the eye imaginal disc with Psn antibody L7 and ELAV antibody, which recognizes a neuronal antigen (Bier et al., 1988) , showed that Psn is primarily localized in the cytoplasm of immature photoreceptor neurons ( Fig. 4A-C) . As in the embryo, Psn is preferentially localized near the apical membranes of the imaginal columnar epithelial cells. Psn localization at the apical membranes of imaginal wing discs results in prominently stained disc surface folds in histological preparations (Fig. 3A) . No anti-Psn staining was seen in nuclei of the larval discs or pupal disc-derived structures (Fig.  3B ,C). In the pupal eye disc, secondary and tertiary pigment cell precursors appear to express Psn at higher levels than other cell types, although the protein was detected at lower levels in primary pigment cell, photoreceptor cell and cone cell precursors (Fig. 3C) . In later stages of pupal eye disc development, Psn is also expressed at high levels in cells which give rise to the interommatidial bristles of the adult eye (Fig. 3D) . Psn is expressed at a very high level in certain regions of the larval and pupal brain, postembryonic CNS structures that contribute to the adult nervous system. In the larval brain and optic lobes, Psn expression is enhanced in part of the optic lobe anlagen, presumably in undifferentiated neurons that give rise to optic lobe structures of the adult brain (Fig. 3E) . Intense Psn expression in the developing medulla, an optic lobe structure, was readily visible as an intensely labeled crescent-shaped structure proximal to the pupal eye disc (Fig. 3F) .
Colocalization of Drosophila Psn and Notch
Given the genetic evidence that Psn might play a role in Notch signaling, we chose several tissues known to require Notch activity or to exhibit modulated Notch expression during cellular patterning and investigated both the general and subcellular colocalization of Psn and Notch. Using Psn- Fig. 2 . Presenilin expression during Drosophila oogenesis and embryogenesis. Developing ovarioles and a 0-16 h collection of embryos were stained with Psn antibody L7 and visualized by confocal microscopy. (A) The developmental stages of the oocyte can be simultaneously observed in a single ovariole. Psn is expressed ubiquitously in all cells of the germarium (gm) and early stage egg chambers (ec) (A). In later stage egg chambers, Psn is enriched in nurse cells (nc) and follicle cells (fc) and is absent from the oocyte (oc) (B-E). Psn is primarily localized in the cytoplasm (A-D) and on the apical nurse cell membranes (arrow in D). In nurse cells, cytoplasm around the nucleus (n) extends into nuclear membrane folds around the nucleus, resulting in patchy Psn staining in nuclear regions in certain confocal sections (B,C). During embryogenesis, Psn expression is detected as early as the blastoderm stage, in which Psn is primarily seen at the cell membrane as well as within the cytoplasm of the blastoderm cells that occupy the periphery of the entire embryo (F,G). Starting from stage 8 embryos, Psn levels remain high in ectodermal tissues (arrows in J) and lower in mesodermal and endodermal tissues. In epidermal tissues, such as the hindgut (hg), where Psn levels remain high during gastrulation, the protein is localized in a polarized manner at the apical regions of the epithelial cells (arrows in H). In stage 14 embryos when the ventral nerve cord (vnc) of the embryonic central nervous system is formed, Psn is present in the ventral nerve cord at a level comparable to surrounding tissues (I,K). Intense signal in the center of the embryo is due to yolk autofluorescence (y). A-G, I-K, anterior at left; H, anterior at bottom. specific antibodies and a Notch antibody that recognizes the extracellular EGF-homologous region of Notch (Fehon et al., 1990; Kooh et al., 1993) , we found that generally the two proteins are coexpressed in embryos, egg chambers, and larval and pupal eye primordia. In the ventral embryonic ectoderm (Fig. 5D-F) , where Notch has a well-documented role in neuroblast specification, there is a high degree of coexpression and subcellular colocalization. High levels of colocalization are also seen in developing nurse cells (Fig. 5P-R ) and blastoderm embryos (Fig. 5A-C) , while less extensive, although still considerable colocalization is apparent in the larval eye disc (Fig. 5G-L ) and pupal retina (Fig. 5M-O) . The reduced subcellular colocalization of Notch and Psn in these postembryonic tissues may be due to their columnar architecture, with its pronounced longitudinal separation of different cellular compartments that are selectively imaged by confocal microscopy.
In all tissues examined, close inspection revealed subtle differences in the subcellular localization of these two proteins. For example, although both proteins are found near cell membranes of most tissues, the Psn level in the cytoplasm is relatively higher than Notch, especially in larval discs (Fig. 5G-I ) and the pupal retina (Fig. 5M-O) . In follicle cells, Psn is also distributed along cell membranes as well as throughout the cytoplasm while Notch staining was more highly concentrated along cell membranes (Fig.  5P-R) . Furthermore, largely nonoverlapping vesicular staining for both proteins is seen in the larval eye disc (Fig. 5J-L) . The ring canals of egg chambers also display Presenilin immunoreactivity but no detectable Notch protein (Fig. 5P-R) . Finally, even in the embryonic ventral ectoderm where colocalization is generally very high, the two proteins do not completely colocalize at the subcellular level ( Fig. 5D-F) . In nurse cell nuclei (ncn), weak Psn staining in the nuclear region (D) does not overlap with DNA stained with propidium iodide (E) and appears to result from cytoplasmic Psn that extends into the focal plane due to irregular folding of the nuclear membrane of nurse cells. Psn is also excluded from follicle cell nuclei (fcn in E). In G-I, Psn is clearly not localized within the nuclear membrane (nm) stained by wheat germ agglutinin. A-C, anterior at left; D-I, anterior at top.
Discussion
Structure and overall expression pattern of the Drosophila Psn gene
The Drosophila Psn gene consists of nine exons and eight introns that span ∼2.4 kb of genomic DNA. The Psn protein displays similar levels of amino acid sequence identity to both human Presenilin 1 and 2 (∼50%) and a lesser degree of identity to the C. elegans Presenilin-like proteins Sel-12 and Hop-1 (∼45% and ∼30%, respectively). Although two Presenilin genes have been reported for both C. elegans and for mammalian species (Levy-Lahad et al., 1995; Rogaev et al., 1995; Sherrington et al., 1995; Li and Greenwald, 1997) , our search for homologues in Drosophila has uncovered only a single Presenilin gene, in agreement with other studies (Boulianne et al., 1997) . However, alternative splicing of the sole identified Psn gene of Drosophila is predicted to generate two protein isoforms that differ with respect to a 14-amino-acid insertion in the large hydrophilic loop domain. The functional significance of these two isoforms is unknown at present.
To assess the role of Presenilin in Drosophila development and its potential involvement in Notch signaling, we analyzed the expression pattern and subcellular localization of Presenilin using Psn-specific polyclonal antibodies and confocal microscopy. In particular, we compared the levels of Psn in neuronal tissues versus nonneuronal tissues, given the causative link between human Presenilin mutations and early-onset Alzheimer's disease. In contrast to enhanced expression of fly Psn mRNA in the embryonic CNS reported previously (Hong and Koo, 1997), we detect no appreciable enrichment in the levels of the protein in neuronal tissues of the embryo by immunohistochemical analysis. Instead, we find that the Psn protein is uniformly and fairly ubiquitously expressed in both embryonic and postembryonic Drosophila tissues, including the developing central and peripheral nervous systems. One exception to this general observation is that Psn is detected at elevated levels in the larval optic lobe anlagen and subsequently at very high levels in the medulla of the pupal optic lobes, suggesting that it may play an especially important role in the patterning of these particular neuronal structures. We also observed relatively uniform expression of Psn protein throughout the larval eye, antennal, wing, and leg imaginal discs, in contrast to a previous mRNA in situ hybridization analysis showing restricted expression of Psn in ocellar primordia of the eye disc and in tibia and femur primordia of the leg disc (Boulianne et al., 1997) .
Subcellular localization of the Drosophila Presenilin protein
Previous studies on the subcellular localization of mammalian Presenilins have identified three distinct cellular compartments where Psn might be localized: (i) the cytoplasm (mainly ER and Golgi compartments), (ii) the cell surface, and (iii) the nucleus, associated with the nuclear membrane and kinetochore (Cook et al., 1996; Kovacs et al., 1996; Culvenor et al., 1997; Dewji and Singer, 1997; . In virtually all cell types that we examined, Drosophila Psn is rather evenly distributed in the cytoplasm from regions beneath the cell surface to perinuclear regions in a diffuse granular pattern, with no apparent enhanced localization in ER/Golgi structures. These discrepancies may reflect divergent subcellular functions and localizations for the fly protein relative to its mammalian homologues in certain cell types, or they may be a consequence of examining endogenous protein levels in vivo rather than overexpressed protein accumulation in cultured cell models. Consistent with the latter possibility, we also notice a vesicular, perinuclear accumulation of Psn in S2 cells overexpressing the fly Psn protein, as expected for an ER/Golgitype localization (data not shown). A similarly punctate, juxtanuclear distribution of mouse Presenilin 1 has also been found to be more diffuse and extensive than Golgi markers (Culvenor et al., 1997) . Our data suggest that endogenous Drosophila Psn is mainly localized within vesicular structures throughout the cytoplasm, including but not limited to ER/Golgi structures. The ER/Golgi distribution of mammalian Presenilin proteins has been taken as evidence that these proteins are involved in protein synthesis, trafficking, or export-coupled processing of substrate proteins (reviewed in Haass, 1997) . The more generalized cytoplasmic distribution of fly Psn is also consistent with such ideas. In addition, accumulation of Drosophila Psn at apical cell regions near the cell surface in some tissues, together with similar observations in other animals, raises the possibility that Psn may be directly involved in events at the cell surface, such as receptor insertion into the plasma membrane, the exchange of signals between cells, or the transmission of signaling activities from the cell membrane into the interior of the cell.
A recent investigation of Presenilin 2 expression in primary human fibroblasts and lymphoblastoid cells reported protein localization at the inner face of the nuclear membrane and associated with kinetochores of the chromosomes . These findings were taken as evidence that Presenilin 2 regulates chromosome segregation and that Alzheimer's disease-associated mutants cause the neuropathological accumulation of amyloid protein by inducing chromosome nondisjunction in developing brain tissues. However, examination of Psn protein levels at the nuclear membrane in our double-staining experiments with wheat germ agglutinin failed to reveal any detectable Psn in the nuclear membranes or nucleoplasm in Drosophila, arguing against a nuclear function for the protein.
Colocalization of Presenilin and Notch in fly tissues
We compared the expression patterns and subcellular distributions of Presenilin and the Notch receptor in selected tissues, since Presenilins may participate in Notch-mediated signaling events. In C. elegans, mutations in the Presenilin homologue sel-12 were first isolated as suppressors of a constitutively activated form of lin-12, a member of the Notch family, and RNA interference experiments with a second nematode Presenilin gene, hop-1, suggests that it also participates in Lin-12/Notch signaling (Levitan and Greenwald, 1995; Li and Greenwald, 1997) . Recent evidence that the spatial and temporal features of the mRNA expression pattern of PS1 closely resemble that of Notch1 mRNA in the mouse raises the possibility that the two proteins might be precisely coexpressed in developing tissues (Berezovska et al., 1997) . The availability of well-characterized Drosophila Notch antibodies, together with the Presenilin antibodies we describe here, allowed us to perform a double-label immunohistological analysis that has not been possible in any other organism.
The tissue distribution of the Notch receptor has been carefully documented in Drosophila throughout the developmental stages during which we have chosen to analyze the Psn distribution pattern (Fehon et al., 1991; Kooh et al., 1993) . Our analysis included the ventral embryonic neuroectoderm, which exhibits the classic neural hyperplasia phenotype in lethal Notch mutants, and the developing retina, which displays dynamic modulations in Notch expression levels and subcellular localization. Comparison of the Notch and Psn protein distribution patterns in these tissues reveals many common features. Both proteins are expressed fairly ubiquitously in almost all cells during oogenesis and both are associated with nurse cell membranes. In addition, both proteins are widely expressed throughout embryonic development in epidermal and neuronal cell lineages and both also reveal similar dynamic expression patterns in the ventral ectoderm during embryonic neurogenesis. During this process, both Notch and Psn remain expressed at high levels in epidermal cells but decrease in embryonic neuroblasts soon after they segregate from the surrounding epidermal tissue. Neuronal cell expression of both proteins is relatively low until the CNS is well differentiated, at which time expression of both proteins increases again.
Similar parallels between Notch and Presenilin are observed during the larval and pupal stages. During the development of the imaginal eye disc, both proteins are expressed in all cells of the eye disc epithelium and are enriched in the apical cell regions of these polarized columnar epithelial cells. Both appear to be most abundant in the region of the morphogenetic furrow, which may simply reflect the increased membrane density of the apically constricted cells within the furrow. Intriguingly, during development of the pupal retina, when Notch undergoes a dramatic change in its expression levels at the apical surface of the eye disc and is primarily enriched in the secondary and tertiary pigment cells as well as in cells of the interommatidial bristle apparatus, we see a corresponding modulation in Psn expression, such that Notch and Psn are largely coexpressed during this stage. The high degree of coexpression of these two proteins in tissues with welldocumented requirements for Notch activity lends credence to the notion that Psn may play an important role in Notch signaling in flies, as has been deduced from studies in other species (Levitan and Greenwald, 1995; Li and Greenwald, 1997; Wong et al., 1997) . In this regard, our antibody data are more consistent with the proposed general requirement for Presenilin in Notch signaling than data from mRNA expression studies, which concluded that Psn expression is highly restricted to specific imaginal disc regions and is excluded from certain eye and leg disc cell territories known to be undergoing active Notch signaling (Boulianne et al., 1997) .
Although Notch and Presenilin are coexpressed within many tissues at the cellular level, distinct differences in their subcellular localizations are apparent in some cell types. In general, Notch is more highly restricted to the apical cell region and more tightly associated with cell membranes, clearly outlining the apical profiles of the cells when visualized by confocal optical sectioning. In contrast, Psn is detected at more equivalent levels both in the cytoplasm and at the cell membrane, such that Psn immunostaining appears to be more diffuse and graded than Notch in the same cell types. It is worth noting that Notch has long been known to accumulate at considerable levels throughout the cytoplasm of transfected S2 cells or wild-type Drosophila tissues (Fehon et al., 1990 (Fehon et al., , 1991 . Since Notch is believed to act as a cell surface receptor for extracellular signals, the functional significance of this cytoplasmic accumulation is unclear, but it may be related to the similarly diffuse cytoplasmic distribution of Presenilin. Finally, in tissues such as the imaginal eye disc that display considerable vesicular immunostaining for both Notch and Psn, confocal analysis reveals that the two proteins are localized to largely or completely nonoverlapping vesicle subpopulations. Since the cytoplasmic and vesicular Notch protein distributions may correspond to newly synthesized Notch being transported to the cell surface and ligand-bound Notch being internalized in multivesicular bodies for lysosomal degradation, respectively (Fehon et al., 1990 (Fehon et al., , 1991 , colocalization of Presenilin with only the cytoplasmic Notch fraction may indicate that Presenilin is associated with Notch during receptor maturation or trafficking, and not during receptor endocytosis.
Several studies have implicated mammalian Presenilin in altered proteolytic processing of APP. Alzheimer's diseaseassociated mutant forms of Presenilin cause elevated levels of amyloid-b(1-42) production, possibly by altering the relative frequency of cleavage at the g-secretase sites of APP (reviewed in Haass, 1997) . Mice deficient for PS1 activity display normal a-and b-secretase cleavage of APP, but strongly reduced g-secretase cleavage of APP, suggesting that the biological function of Presenilin may be to regulate the unusual intramembranous cleavage of APP, and perhaps other proteins, by g-secretases (De Strooper et al., 1998) . Proteolytic processing of invertebrate and mammalian Notch proteins in the trans-Golgi network is thought to contribute to receptor maturation by cleaving at extracellular sites, leading to production of a functional Notch heterodimer (Blaumueller et al., 1997; Pan and Rubin, 1997) . A ligand-dependent cleavage event, either intramembranous or just proximal to the membrane, may be responsible for generating a biologically active intracellular fragment of Notch with potent signaling properties (Kopan et al., 1996; Schroeter et al., 1998; Struhl and Adachi, 1998) . Although there is currently no evidence for a requirement of Presenilin in Notch processing, the similarities in the locations of the a-, b-, and g-secretase cleavage positions of APP to the extracellular and putative intramembranous or submembranous cleavage sites of Notch suggest that Presenilin may play analogous roles in regulating the processing of both of these single-pass transmembrane proteins. Although further studies are required to elucidate the exact role, if any, of Presenilin in Notch proteolysis and signaling, our confocal immunolabeling analysis reveals widespread coexpression of Presenilin and Notch in various Drosophila tissues, consistent with a possible functional link between the two proteins in cell-fate specification events throughout fly development.
Experimental procedures
Cloning and sequencing
Degenerate oligonucleotide primers of the following sequences were used for PCR. Primer 1, 5′-TA(C/ T)AA(G/A)ITIAT(C/T)CA(C/T)GGITGG(C/T)T(G/C)AT-3′; primer 2, 5′-GTCCACTC(G/C)GG(G/C)A(A/G)(A/ G)TACTT(A/G)ATGAA(G/C)AC(G/C)A(A/G)IGCCAT-3′. PCR reactions were performed using Drosophila genomic DNA as a template with the following parameters: 94°C, 30 s; 54°C, 30 s; 72°C, 1 min, repeated for 30 cycles. PCR products were subcloned into pBS-SK II (Stratagene, La Jolla, CA) and sequenced. The correct PCR product was used to screen a l/ZapII phage Drosophila 0-16 h embryonic cDNA library (Fehon et al., 1994 ) to obtain several full-length Presenilin cDNA clones, which were subcloned into pBS-SK II and sequenced. Sequence alignments were performed with MacVector 6.0 software.
Antibody preparation
Two peptide sequences from the Drosophila Psn protein, an N-terminal peptide (NH 2 -(C)QRNNYGSSNQDQPD-COOH; amino acids 41-54) and a loop peptide (NH 2 -(C)QRTGNSHPRQNQRDD-COOH; amino acids 362-376) were synthesized and conjugated to KLH for use as immunogens. Polyclonal antisera and ascites were successfully raised in mice against only the loop peptide (Zymed, South San Francisco, CA). Affinity purification of antibody was performed using the ImmunoPure Ag/Ab Immunobilization Kit (Pierce Chemical Co., Rockford, IL). In addition, a partial Presenilin cDNA encoding amino acids 358-483 was subcloned into the pTrcHis vector (Invitrogen, Carlsbad, CA) with an in frame N-terminal His tag. The fusion cDNA was expressed in Escherichia coli, purified using the Talon metal affinity resin column (Clontech, Palo Alto, CA), and injected into mice (Covance Research Products, Denver, PA).
Immunohistochemistry
Immunostaining of embryos and developing tissues was performed as described previously (Fehon et al., 1991) . Affinity-purified Psn antibody L7 was used at a 1:100 dilution. For double-label experiments, rat Notch antibody Rat1 (a gift of S. Artavanis-Tsakonas) was used at a 1:1000 dilution, rat ELAV antibody 7E8A10 (a gift of G.M. Rubin) was used at a 1:200 dilution, FITC-conjugated goat anti-rat and Cy3-conjugated goat anti-mouse double-label grade secondary antibodies (Jackson ImmunoResearch, West Grove, PA) were used at a 1:250 dilution each, and wheat germ agglutinin (a gift of T.A. Jongens) was used at a 1:5000 dilution. Embryos and other immunostained tissues were mounted in 90% glycerol, 10% 1 M Tris (pH 8.0), 0.5% n-propyl gallate, and examined with a Leica confocal microscope.
S2 cell transfection and immunodetection
To express Psn in cultured cells, the 1.8 kb EcoRI/XbaI fragments encoding either the Psn isoform containing the 14-amino-acid loop insertion or the Psn isoform lacking the 14-amino-acid insertion were cloned into pCaSpeR-hs (Thummel and Pirrotta, 1992) . To monitor transfection efficiency using lipofectin reagent (Gibco BRL, Gaithersburg, MD), a pCaSpeR-hs-GFP construct was generated by excising the green fluorescence protein (GFP) cassette from the pGreenlantern plasmid (Gibco) as a NotI fragment and inserting it into the NotI site of pCaSpeR-hs. S2 cells were maintained in Schneider's Drosophila medium with 10% fetal calf serum and 1% Penicillin-Streptomycin (Gibco). S2 cells were cotransfected with pCaSpeR-hs-Psn and pCaSpeR-hs-GFP (2.5 mg each) and subjected to two 1-h 38°C heat pulses each followed by a 1-h recovery period at 25°C, then fixed and stained as described previously (Fehon et al., 1990) .
